Biotricity, Inc. (BTCY)

NASDAQ: BTCY · IEX Real-Time Price · USD
-0.009 (-1.05%)
At close: Nov 28, 2023, 3:11 PM
-0.001 (-0.13%)
After-hours: Nov 28, 2023, 4:00 PM EST

Total Valuation

Biotricity has a market cap or net worth of $7.10 million. The enterprise value is $27.57 million.

Market Cap 7.10M
Enterprise Value 27.57M

Important Dates

The last earnings date was Tuesday, November 14, 2023, after market close.

Earnings Date Nov 14, 2023
Ex-Dividend Date n/a

Share Statistics

Biotricity has 8.77 million shares outstanding. The number of shares has increased by 1.77% in one year.

Shares Outstanding 8.77M
Shares Change (YoY) +1.77%
Shares Change (QoQ) +0.49%
Owned by Insiders (%) 18.54%
Owned by Institutions (%) 5.42%
Float 7.03M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.67
Forward PS 0.99
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.48
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.29

Current Ratio 0.29
Quick Ratio 0.17
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -4.01

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -261.60%
Return on Capital (ROIC) n/a
Revenue Per Employee $202,067
Profits Per Employee -$310,687
Employee Count 55
Asset Turnover 1.70
Inventory Turnover 2.14


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -87.32% in the last 52 weeks. The beta is 2.35, so Biotricity's price volatility has been higher than the market average.

Beta (1Y) 2.35
52-Week Price Change -87.32%
50-Day Moving Average 1.63
200-Day Moving Average 2.89
Relative Strength Index (RSI) 27.75
Average Volume (30 Days) 23,804

Short Selling Information

The latest short interest is 141,139, so 1.61% of the outstanding shares have been sold short.

Short Interest 141,139
Short Previous Month 135,095
Short % of Shares Out 1.61%
Short % of Float 2.01%
Short Ratio (days to cover) 4.30

Income Statement

In the last 12 months, Biotricity had revenue of $11.11 million and -$17.09 million in losses. Loss per share was -$1.96.

Revenue 11.11M
Gross Profit 6.85M
Operating Income -11.01M
Pretax Income -16.29M
Net Income -17.09M
EBITDA -12.52M
EBIT -13.04M
Loss Per Share -$1.96
Full Income Statement

Balance Sheet

The company has $1.28 million in cash and $21.40 million in debt, giving a net cash position of -$20.12 million or -$2.29 per share.

Cash & Cash Equivalents 1.28M
Total Debt 21.40M
Net Cash -20.12M
Net Cash Per Share -$2.29
Equity / Book Value -26.73M
Book Value Per Share -3.05
Working Capital -12.65M
Full Balance Sheet

Cash Flow

Operating Cash Flow -9.28M
Capital Expenditures n/a
Free Cash Flow -9.28M
FCF Per Share -$1.06
Full Cash Flow Statement


Gross margin is 61.66%, with operating and profit margins of -99.02% and -153.75%.

Gross Margin 61.66%
Operating Margin -99.02%
Pretax Margin -146.60%
Profit Margin -153.75%
EBITDA Margin -112.61%
EBIT Margin -117.33%
FCF Margin -83.50%

Dividends & Yields

Biotricity does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -229.24%
FCF Yield -124.49%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -1.77%
Shareholder Yield -1.77%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Hold
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on July 3, 2023. It was a reverse split with a ratio of 1:6.

Last Split Date Jul 3, 2023
Split Type Reverse
Split Ratio 1:6


Biotricity has an Altman Z-Score of -31.39 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -31.39
Piotroski F-Score 4